"GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors." Diagnostics (Basel). 2022;12(3).
Anne Cress, PhD
Megha Padi, PhD
Gregory C. Rogers, PhD
Noel Warfel, PhD
Display on main departmental publications list:
Yes